Revusiran
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Revusiran, covering 2016-02-05 to 2019-03-28. Get the full timeline:
Most recent: Clinical Trial Update: The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant [Phase 2]